Yield10 Bioscience Inc
NASDAQ:YTEN
Yield10 Bioscience Inc
Revenue
Yield10 Bioscience Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Yield10 Bioscience Inc
NASDAQ:YTEN
|
Revenue
$60k
|
CAGR 3-Years
-58%
|
CAGR 5-Years
-36%
|
CAGR 10-Years
-34%
|
|
Abbvie Inc
NYSE:ABBV
|
Revenue
$54.3B
|
CAGR 3-Years
6%
|
CAGR 5-Years
11%
|
CAGR 10-Years
11%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Revenue
$27.1B
|
CAGR 3-Years
3%
|
CAGR 5-Years
4%
|
CAGR 10-Years
9%
|
|
Amgen Inc
NASDAQ:AMGN
|
Revenue
$28.2B
|
CAGR 3-Years
4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
4%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Revenue
$9.9B
|
CAGR 3-Years
17%
|
CAGR 5-Years
26%
|
CAGR 10-Years
23%
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Revenue
$13.1B
|
CAGR 3-Years
16%
|
CAGR 5-Years
14%
|
CAGR 10-Years
20%
|
Yield10 Bioscience Inc
Revenue Breakdown
Breakdown by Geography
Yield10 Bioscience Inc
Breakdown by Segments
Yield10 Bioscience Inc
Total Revenue:
60k
USD
|
Grant Revenue:
60k
USD
|
See Also
What is Yield10 Bioscience Inc's Revenue?
Revenue
60k
USD
Based on the financial report for Dec 31, 2023, Yield10 Bioscience Inc's Revenue amounts to 60k USD.
What is Yield10 Bioscience Inc's Revenue growth rate?
Revenue CAGR 10Y
-34%
Over the last year, the Revenue growth was -87%. The average annual Revenue growth rates for Yield10 Bioscience Inc have been -58% over the past three years , -36% over the past five years , and -34% over the past ten years .